Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in Health Policy and Management and in Epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. Her research interests include evidence-based medicine. Dr. Segal and her team have been tapped by the Food and Drug Administration (FDA) to conduct research to find out why physicians opt to prescribe costlier brand-name drugs when generic ones are available. She is on the Fellowship Advisory Committee at Johns Hopkins. She serves as the principal investigator of the Primary Care and Health Services Research Training Program. She is a member of Phi Beta Kappa and Alpha Omega Alpha.

Dr. Segal serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both at the Bloomberg School of Public Health. Additionally, she’s the director of the Pharmacoepidemiology Program.

Dr. Segal received a BS from Pennsylvania State University. She earned her MD from the University of Pittsburgh School of Medicine and her MPH from Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and performed a fellowship in internal medicine at Johns Hopkins.